author-photo

Alain M. Schoepfer

University of Bern
McMaster University

98

Papers

3744

Citations

Citation Trend

Filter By

Papers (98) Sort By

JournalConferenceOthers

Eine 12-wöchige Induktionstherapie mit der Budesonid-Schmelztablette führt zu einer signifikanten Verbesserung sowohl der inflammatorischen als auch der fibrotischen endoskopischen Zeichen bei Erwachsenen mit aktiver eosinophiler Ösophagitis und inkompletter Response nach 6 Wochen

2021
Show All
- Source
- Cite
- Save
Citations (0)
540 FLUTICASONE PROPIONATE ORALLY DISINTEGRATING TABLET (APT-1011) IMPROVES HISTOLOGIC, ENDOSCOPIC AND SYMPTOMATIC RESPONSES IN EOSINOPHILIC ESOPHAGITIS PATIENTS WITH FIBRO-STENOTIC FEATURES: RESULTS FROM A PHASE 2B TRIAL

2021 Gastroenterology
Show All
- Source
- Cite
- Save
Citations (1)
Long-Lasting Dissociation of Esophageal Eosinophilia and Symptoms Following Dilation in Adults with Eosinophilic Esophagitis

2021
Show All
- Source
- Cite
- Save
Citations (0)
Fr172 LOW RATES OF GLUCOCORTICOID-RELATED ADVERSE EFFECTS WITH LONG-TERM TREATMENT OF EOSINOPHILIC ESOPHAGITIS WITH FLUTICASONE PROPIONATE ORALLY DISINTEGRATING TABLET (APT-1011): RESULTS FROM 52 WEEKS OF EXPOSURE IN A PHASE 2B TRIAL.

2021 Gastroenterology
Show All
- Source
- Cite
- Save
Citations (0)
S381 Esophageal Eosinophil Count Does Not Correlate With the Endoscopic Reference Score Remodeling Subscore in Placebo-Treated Eosinophilic Esophagitis Patients in the Phase 2 Proof-of-Concept and Phase 3 TREET Studies

2021 The American Journal of Gastroenterology
Show All
- Source
- Cite
- Save
Citations (0)
[Fecal microbiota transplantation: from the evidence to the realty of the field].

2021 Revue médicale suisse
Show All
- Source
- Cite
- Save
Citations (0)
S353 Time to Clinically Meaningful Improvement in Dysphagia Frequency in Adults with Eosinophilic Esophagitis: A Post-Hoc Analysis From a Phase 2b Trial of APT-1011, a Fluticasone Propionate Oral Disintegrating Tablet

2021 The American Journal of Gastroenterology
Show All
- Source
- Cite
- Save
Citations (0)
Eine neue Budesonid-Schmelztablette ist hochwirksam bei der Re-Induktion der klinischen Remission im Falle eines klinischen Rückfalls bei erwachsenen Patienten mit eosinophiler Ösophagitis: Ergebnisse der EOS-2-Studie

2021
Show All
- Source
- Cite
- Save
Citations (0)
Crohn's versus cancer - comparison of functional and surgical outcomes after right-sided resections.

2020 Digestive Diseases
Show All
- Source
- Cite
- Save
Citations (2)
Mo1182 AN EPISODE-BASED, PATIENT-REPORTED OUTCOME MEASURE OF DYSPHAGIA ACCURATELY CAPTURES RESPONSE TO TREATMENT WITH APT-1011 IN A PHASE 2B, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, CLINICAL TRIAL IN ADULTS WITH EOSINOPHILIC ESOPHAGITIS

2020 Gastroenterology
Show All
- Source
- Cite
- Save
Citations (0)

© Copyright 2015-2020 Acemap, Inc. Shanghai Jiao Tong University.

沪ICP备18028330号